by Zachary | Apr 16, 2025 | Emerging Trends
Chris Moore, MBA & Jayden Lee, EMBA, BCACP, PharmD Pharmacogenomics in Rare Disease: Challenges and Opportunities. How rare is rare? In the U.S. alone, around 30 million people – roughly 1 in 10 – live with a rare disease (Rare Disease, NIH, 2025). 80% of rare...
by Zachary | Apr 12, 2025 | Emerging Trends
Jennifer Tovar, PharmD & Husna Rahim, PharmD Genomic Warfare: Outsmarting Cancer Care with Pharmacogenomics. How can pharmacogenomics (PGx) maximize efficacy and minimize toxicity of cancer treatment? To outsmart cancer, PGx offers a genomic arsenal that enables...
by Zachary | Apr 12, 2025 | Emerging Trends
Ayse Ulgen, PhD, MGM & Zachary Brooks, PhD AI Agents in Pharmacogenomics: New Drugs and Predictive Analytics. How can predictive models powered by artificial intelligence (AI) enhance drug development in pharmacogenomics (PGx) research? AI is a powerful tool...
by Zachary | Mar 26, 2025 | Emerging Trends
Husna Rahim, PharmD & Archana Gurudu Translating Adult-Derived Pharmacogenomic Data to Pediatric Populations. Can pharmacogenomic (PGx) data derived from adult-studied populations translate to pediatric patients? While PGx data from adults serves as a universal...
by Zachary | Mar 20, 2025 | Emerging Trends
Miley Nguyen, PharmD & Niharika Koppolu Pharmacogenomics in Pregnancy: Personalized Medicine for Expecting Mothers. What if the medications prescribed during pregnancy could be tailored to the genetic profile of the mother and her unborn child? Pharmacogenomics...
by Zachary | Mar 5, 2025 | Emerging Trends
Raymond Lorenz, PharmD, BCPP & Ansha Gupta Integration of Pharmacogenomics in Autism Management. What if there were a way to alleviate some of the frustrations that go along with autism? Autism Spectrum Disorder (ASD) is a genetic neurodevelopmental condition....
